Imosec M 2mg/125mg Tablet
By Imosec M
Rx
4 Tablet in a Strip

Composition
Loperamide(2mg) + Simethicone(125mg)

Manufacturer - Janssen Pharmaceuticals
Johnson & Johnson Private Limited., 501 Arena Space, Behind Majas Bus Depot, Off Jogeshwari Vikhroli Link Road, Jogeshwari (E), Mumbai 400 060

Expires on or after
February, 2027

liver
Imosec M 2mg/125mg Tablet needs to be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Imosec M 2mg/125mg Tablet in such cases. It is advisable to seek guidance from a healthcare provider regarding the use of this medication if you have liver issues.

kidney
Limited information is available on the use of Imosec M 2mg/125mg Tablet in patients with kidney disease. Please consult your doctor.

alcohol
When taking Imosec M 2mg/125mg Tablet, be cautious as it may lead to increased drowsiness when combined with alcohol.

driving
Avoid driving if Imosec M 2mg/125mg Tablet causes drowsiness, blurred vision, or affects alertness. These effects can impair driving skills and pose a risk to safety.

pregnancy
Imosec M 2mg/125mg Tablet is considered unsafe during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Kindly consult your doctor before using Imosec M 2mg/125mg Tablet during pregnancy.

breastfeeding
Imosec M 2mg/125mg Tablet is considered safe for breastfeeding as per limited data, indicating minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹25
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025